Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Agnes Saint-Raymond

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Lancet. Child & Adolescent Health|September 1, 2018
Availability of paediatric information in European Medicines Agency approvalsThomas J Hwang, Paolo A Tomasi, Agnes Saint-Raymond, et al.
International Journal of Pharmaceutics|August 14, 2012
The EMA quality guideline on the pharmaceutical development of medicines for paediatric useDiana A van Riet-Nales, Siri Wang, Agnes Saint-Raymond, et al.
Archives of Disease in Childhood|April 8, 2016
Important issues in the justification of a control treatment in paediatric drug trialsLauren E Kelly, Elin Haf Davies, Agnes Saint-Raymond, et al.
Paediatric Drugs|November 25, 2015
Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction ReportsKevin V Blake, Agnes Saint-Raymond, Cosimo Zaccaria, et al.
Expert Review of Clinical Pharmacology|December 23, 2020
Reliance: a smarter way of regulating medical products - The IPRP surveyPetra Doerr, Marie Valentin, Nobumasa Nakashima, et al.
International Journal of Pharmaceutics|November 13, 2013
Comments on the EMA draft guideline: final steps towards a harmonized view between regulators and industryDiana A van Riet Nales, Piotr Kozarewicz, Siri Wang, et al.
Expert Review of Clinical Pharmacology|August 10, 2022
Reliance is key to effective access and oversight of medical products in case of public health emergenciesAgnes Saint-Raymond, Marie Valentin, Nobumasa Nakashima, et al.
Paediatric Anaesthesia|January 20, 2011
Role of modeling and simulation in pediatric investigation plansEfthymios Manolis, Tariq Eldirdiry Osman, Ralf Herold, et al.
Paediatric Drugs|June 6, 2014
Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilanceKevin V Blake, Cosimo Zaccaria, Francois Domergue, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|July 16, 2010
Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessorsBeatriz Silva-Lima, Mette Due Theilade-Thomsen, Jacqueline Carleer, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Lancet. Child & Adolescent Health|September 1, 2018
Availability of paediatric information in European Medicines Agency approvalsThomas J Hwang, Paolo A Tomasi, Agnes Saint-Raymond, et al.
International Journal of Pharmaceutics|August 14, 2012
The EMA quality guideline on the pharmaceutical development of medicines for paediatric useDiana A van Riet-Nales, Siri Wang, Agnes Saint-Raymond, et al.
Archives of Disease in Childhood|April 8, 2016
Important issues in the justification of a control treatment in paediatric drug trialsLauren E Kelly, Elin Haf Davies, Agnes Saint-Raymond, et al.
Paediatric Drugs|November 25, 2015
Enhanced Paediatric Pharmacovigilance at the European Medicines Agency: A Novel Query Applied to Adverse Drug Reaction ReportsKevin V Blake, Agnes Saint-Raymond, Cosimo Zaccaria, et al.
Expert Review of Clinical Pharmacology|December 23, 2020
Reliance: a smarter way of regulating medical products - The IPRP surveyPetra Doerr, Marie Valentin, Nobumasa Nakashima, et al.
International Journal of Pharmaceutics|November 13, 2013
Comments on the EMA draft guideline: final steps towards a harmonized view between regulators and industryDiana A van Riet Nales, Piotr Kozarewicz, Siri Wang, et al.
Expert Review of Clinical Pharmacology|August 10, 2022
Reliance is key to effective access and oversight of medical products in case of public health emergenciesAgnes Saint-Raymond, Marie Valentin, Nobumasa Nakashima, et al.
Paediatric Anaesthesia|January 20, 2011
Role of modeling and simulation in pediatric investigation plansEfthymios Manolis, Tariq Eldirdiry Osman, Ralf Herold, et al.
Paediatric Drugs|June 6, 2014
Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilanceKevin V Blake, Cosimo Zaccaria, Francois Domergue, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|July 16, 2010
Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessorsBeatriz Silva-Lima, Mette Due Theilade-Thomsen, Jacqueline Carleer, et al.
Pageof 3